Skip to main content
Elsevier
View Cart
My account

Books in Psychoneuropharmacology

BooksJournals

    • Neuropsychopharmacology

      • 1st Edition
      • May 10, 2023
      • Jahangir Moini + 2 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 5 9 7 4 2
      • eBook
        9 7 8 0 3 2 3 9 5 9 7 3 5
      Neuropsychopharmacol... reviews the principles of pharmacology with a focus on the central nervous system and autonomic nervous system. Beyond autonomic and central nervous system pharmacology, this volume uniquely discusses psychiatric disorders and the pharmacological interventions that are available for conditions including depression, schizophrenia and anxiety disorders. With a focus on these specific body systems, readers will see end-of-chapter questions that offer real-world case studies, as well as multiple-choice questions for further learning. Beneficial features and content also include two extensive examination tests, which each contain 100 questions for better learning or to be used in teaching, and a glossary. Helpful appendices cover high-alert medications and toxicology effects on the nervous system. Each chapter will contain classifications of medications, pharmacokinetics, mechanism of action, clinical indications and toxicities.

    • Prof. of Drug Substances, Excipients and Related Methodology

      • 1st Edition
      • Volume 46
      • January 16, 2021
      • Abdulrahman Al-Majed
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 1 2 7 1
      • eBook
        9 7 8 0 1 2 8 2 4 1 2 8 8
      Profiles of Drug Substances, Excipients, and Related Methodology, Volume 46 contains comprehensive profiles of five drug compounds: Darunavir, Bisoprolol, Betaxolol, Rabeprazole and Irbesartan. In addition, the work contains a chapter reviewing Bioassay Methods and Their Applications in Herbal Drug Research. The comprehensive reviews in the book cover all aspects of drug development and the formulation of drugs, helping readers understand how the drug development community remains essential to all phases of pharmaceutical development. In addition, this work answers why such profiles are of immeasurable importance to workers in the field. The scope of the Profiles series encompasses review articles and database compilations that fall within one or more of the following five broad categories: Physical Profiles of Drug Substances and Excipients, Analytical Profiles of Drug Substances and Excipients, ADME Profiles of Drug Substances and Excipients, Methodology Related to the Characterization of Drug Substances and Excipients, and Methods of Chemical Synthesis.

    • Profiles of Drug Substances, Excipients, and Related Methodology

      • 1st Edition
      • Volume 45
      • March 10, 2020
      • Harry G. Brittain
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 3 2 3 1
      • eBook
        9 7 8 0 1 2 8 2 0 3 2 4 8
      Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.

    • Profiles of Drug Substances, Excipients, and Related Methodology

      • 1st Edition
      • Volume 43
      • April 17, 2018
      • Harry G. Brittain
      • English
      • Hardback
        9 7 8 0 1 2 8 1 5 1 2 5 9
      • eBook
        9 7 8 0 1 2 8 1 5 1 2 6 6
      Profiles of Drug Substances, Excipients, and Related Methodology, Volume 43 presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles and database compilations that fall within a variety of categories, with this release focusing on Ganciclovir, Mirtazapine, Tolfenamic Acid, Mid-Infrared Spectroscopy of Pharmaceutical Solids, and the Validation of Chromatographic Methods of Analysis: Application for drugs that derived from herbs.

    • Life-Threatening Effects of Antipsychotic Drugs

      • 1st Edition
      • August 12, 2016
      • Peter Manu + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 8 0 3 3 7 6 0
      • eBook
        9 7 8 0 1 2 8 0 3 3 9 0 6
      Life-Threatening Effects of Antipsychotic Drugs describes in detail more than 20 life-threatening effects associated with antipsychotics, presents the best available data on their incidence and case fatality, and gives comprehensive advice on diagnosis, management and preventive strategies. In addition, the book discusses the benefit of antipsychotic medication in a range of therapeutic indications, and demonstrates the gain in life-expectancy associated with clozapine use in severe mental illness despite its serious, potentially life-threatening adverse effects.

    • Emerging Targets and Therapeutics in the Treatment of Psychostimulant Abuse

      • 1st Edition
      • Volume 69
      • January 29, 2014
      • Linda P. Dwoskin
      • English
      • Hardback
        9 7 8 0 1 2 4 2 0 1 1 8 7
      • eBook
        9 7 8 0 1 2 4 2 0 1 7 7 4
      This new volume of Advances in Pharmacology presents the emerging targets and therapeutics in the treatment of psychostimulant abuse. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

    • Advances in Drug Research

      • 1st Edition
      • Volume 19
      • October 22, 2013
      • Bernard Testa
      • English
      • eBook
        9 7 8 1 4 8 3 2 8 7 9 9 7
      Each volume in this distinguished series presents authoritative reviews on topics of broad interest in drug research and on novel and established therapeutic classes. Acknowledged experts contribute in areas such as drug design, clinical and molecular pharmacology, drug metabolism, and mechanisms of action. Reviewers have consistently praised Advances in Drug Research for its comprehensive and lucid summaries of up-to-date knowledge.

    • Advances in Drug Research

      • 1st Edition
      • Volume 17
      • October 22, 2013
      • Bernard Testa
      • English
      • eBook
        9 7 8 1 4 8 3 2 8 7 9 7 3
      This volume comprises five authoritative reviews on timely topics in drug research. The first two chapters deal with chemotherapeutic agents (selective antiviral agents and cepham antibiotics) and subsequent chapters deal with the cardiovascular system and topics in neuropharmacology.

    • Advances in Drug Research

      • 1st Edition
      • Volume 18
      • October 22, 2013
      • Bernard Testa
      • English
      • eBook
        9 7 8 1 4 8 3 2 8 7 9 8 0
      Each volume in this distinguished series presents authoritative reviews, both generally, on topics of broad interest in drug research, and specifically, on novel and established therapeutic classes. Acknowledged experts contribute in areas such as drug design, clinical and molecular pharmacology, drug metabolism, and mechanisms of action. Reviewers have consistently praised Advances in Drug Research for its comprehensive and lucid summaries of up-to-date knowledge.

    • Antipsychotic Drugs and Their Side-Effects

      • 1st Edition
      • October 22, 2013
      • Thomas R.E. Barnes
      • English
      • eBook
        9 7 8 1 4 8 3 2 8 8 1 0 9
      In line with other volumes in the Neuroscience Perspectives Series, this volume covers the background, pharmacology, molecular biology, and biochemistry of antipsychotic drugs, together with an overview assessment of the therapeutic considerations. Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including motor side-effects like parkinsonism. Studies show that lowering doses may still produce the antipsychotic effect while lessening the risk of side-effects. As all available antispychotic drugs are able to block dopamine, specifically D2 receptors, doses below the threshold level for producing acute motor disorder can still be therapeutically effective. With the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with better side-effect potential has arisen. Other novel antipsychotic agents include D1 receptor blockers, partial dopamine agonists and non-dopamine drugs such as 5-HT receptor blockers, sigma receptor antagonists and NMDA receptor agonists. This volume reviews both the basic science of the conventional and atypical neuroleptics and their present and potential therapeutic use.